Tag: Significantly

Latest News

LYNPARZA® (olaparib) Phase 3 PAOLA-1 Trial Significantly Increased Progression-Free Survival as First-Line Maintenance Treatment with Bevacizumab for Newly-Diagnosed Advanced Ovarian Cancer

Newsemia
KENILWORTH, N.J.–(BUSINESS WIRE)—- $MRK #MRK–LYNPARZA PAOLA-1 Trial Significantly Increased PFS as 1st-Line Maintenance Treatment with Bevacizumab for Newly-Diagnosed Advanced Ovarian Cancer Source link...
Cardiology

Cannabidiol Interacts Significantly with Everolimus-Report of a Patient with Tuberous Sclerosis Complex.

Newsemia
Related Articles Cannabidiol Interacts Significantly with Everolimus-Report of a Patient with Tuberous Sclerosis Complex. Neuropediatrics. 2019 Sep 20;: Authors: Wiemer-Kruel A, Stiller B, Bast T...
Latest News

Study Demonstrates Significantly Better Quality Cancer Care and Lower Costs with a Value-Based Care Model Implemented by The Oncology Institute and CareMore Health

Newsemia
CERRITOS, Calif.–(BUSINESS WIRE)–The Oncology Institute (TOI), in collaboration with the Stanford University School of Medicine and CareMore Health, today announced data from a study, Enhancing...
Latest News

Detailed Results from Phase III DAPA-HF Trial Showed FARXIGA Significantly Reduced Both the Incidence of Cardiovascular Death and the Worsening of Heart Failure

Newsemia
WILMINGTON, Del.–(BUSINESS WIRE)–AstraZeneca today announced detailed results from the landmark Phase III DAPA-HF trial that showed FARXIGA (dapagliflozin) on top of standard of care reduced...
Pharma / Biotech

Reduction-responsive polypeptide nanomedicines significantly inhibit progression of orthotopic osteosarcoma.

Newsemia
Related Articles Reduction-responsive polypeptide nanomedicines significantly inhibit progression of orthotopic osteosarcoma. Nanomedicine. 2019 Aug 20;:102085 Authors: Yin F, Wang Z, Jiang Y, Zhang T, Wang...

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy